24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

Name: 24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo
Published: 2015
License: Public Domain

Pearl Therapeutics, Inc. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

copd

copd, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

Related documents